查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球INAAT(等温核酸扩增技术)市场:副产品(检测,系统),技术(LAMP,SDA,NASBA,NEAR,HDA),应用(诊断(流感,肝炎,CT/NG,COVID-19,血液筛查),用户,地区预测至2028
市场调查报告书
商品编码
1238669

全球INAAT(等温核酸扩增技术)市场:副产品(检测,系统),技术(LAMP,SDA,NASBA,NEAR,HDA),应用(诊断(流感,肝炎,CT/NG,COVID-19,血液筛查),用户,地区预测至2028

Isothermal Nucleic Acid Amplification Technology Market by Product (Assay, System), Technology (LAMP, SDA, NASBA, NEAR, HDA), Application (Diagnostics (Influenza, Hepatitis, CT/NG, COVID-19), blood screening), End User & Region - Global Forecast to 2028
出版日期: | 出版商: MarketsandMarkets | 英文 226 Pages | 订单完成后即时交付

价格
简介目录

全球 INAAT(等温核酸扩增技术)市场规模预计将从 2023 年的 44 亿美元增长到 2028 年的 68 亿美元，在预测期内以 9.2% 的复合年增长率增长。INAAT 市场的主要驱动因素包括传染病流行率上升,INAAT 产品的推出和批准，以及诊断工具的潜在资金。

从技术来看，2022年LAMP领域的份额将最大。 这是由于全球发达市场和新兴市场对 LAMP 套件的高需求和广泛可用性。

按应用来看，疾病诊断领域预计到 2022 年将占据市场主导地位。 HIV,流感和肝炎患者人数的增加，以及由于加强对传染病的措施而增加使用基于 INAAT 的试剂盒，被认为是市场增长背后的主要因素。

按地区划分，北美所占份额最大。 确保研究资金,诊断行业的发展,艾滋病毒/肝炎/流感患者早期诊断的重要性日益增加以及医疗基础设施的发展等因素是推动市场增长的主要因素。

在本报告中，我们分析了全球 INAAT 市场，包括市场的基本结构和最新情况，驱动和製约市场的主要因素，以及按产品,技术,应用,最终用户和地区划分的市场趋势。前景,市场竞争状况以及主要参与者的概况。

内容

第一章介绍

第二章研究方法论

第 3 章执行摘要

第 4 章重要注意事项

第 5 章市场概述

  • 介绍
  • 市场动态
    • 司机
    • 约束因素
    • 机会
    • 任务
  • 价格分析
  • 价值链分析
  • 生态系统分析
  • 主要会议和活动 (2023-2024)
  • 波特的五力分析
  • 主要利益相关者和采购标准
  • 专利分析
  • 监管分析
  • 影响客户业务的趋势/颠覆

第 6 章 INAAT 市场:按产品分类

  • 简介
  • 化验/试剂盒/试剂
  • 系统

第 7 章 INAAT 市场:按技术分类

  • 简介
  • LAMP(环介导等温扩增)
  • TMA(转录介导的扩增)
  • NEAR(切口□扩增反应)
  • SDA(链置换放大)
  • HDA(解旋□依赖性扩增)
  • NASBA(基于核酸序列的扩增)
  • SPIA(单引物等温扩增)
  • 其他技术

第 8 章 INAAT 市场:按应用

  • 介绍
  • 疾病诊断
    • COVID-19
    • 肝炎
    • CT/NG(沙眼衣原体/淋病奈瑟菌)
    • 流感
    • 艾滋病毒
    • 其他疾病
  • 血液筛查
  • 其他用途

第 9 章 INAAT 市场:按最终用户分类

  • 介绍
  • 医院
  • 参考实验室
  • 教育和研究机构
  • 其他最终用户

第 10 章 INAAT 市场:按地区

  • 介绍
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太国家
  • 拉丁美洲
  • 中东和非洲

第11章竞争格局

  • 介绍
  • 大公司采用的权利收购方式
  • 收益分成分析
  • 市场份额分析
  • 主要公司的企业评估矩阵
  • 前 25 家公司的竞争基准
  • 初创公司/中小企业的业务评估矩阵
  • 初创公司/中小企业的竞争基准
  • 竞争情景和趋势
    • 产品发布
    • 资本交易
    • 其他趋势

第12章公司简介

  • 主要公司
    • HOLOGIC, INC.
    • ABBOTT LABORATORIES
    • GRIFOLS, S.A.
    • BECTON, DICKINSON AND COMPANY
    • MERIDIAN BIOSCIENCE
    • EIKEN CHEMICAL CO., LTD.
    • QUIDEL CORPORATION
    • QIAGEN N.V.
    • NEW ENGLAND BIOLABS
    • DIASORIN S.P.A.
    • BIOMERIEUX SA
    • TECAN TRADING GROUP
    • GENERAL ELECTRIC COMPANY
    • THERMO FISHER SCIENTIFIC
    • OPTIGENE LIMITED
  • 其他企业
    • LGC LIMITED
    • USTAR BIOTECHNOLOGIES
    • TWISTDX LIMITED
    • MAST GROUP LTD.
    • GENOMTEC
    • GENOSENSOR CORPORATION
    • JENA BIOSCIENCE GMBH
    • LIFE SCIENCES ADVANCED TECHNOLOGIES
    • PCR BIOSYSTEMS
    • ATILA BIOSYSTEMS

第13章 附录

简介目录
Product Code: BT 2491

The isothermal nucleic acid amplification technology market is projected to reach USD 6.8 Billion by 2028 from USD 4.4 Billion in 2023, at a CAGR of 9.2% during the forecast period. Increasing prevalence of infectious diseases, launches & approvals for INAAT products and availability of funding for diagnostic tools are various factors projected to drive the growth of the isothermal nucleic acid amplification technology market.

LAMP segment accounted for the largest share of the INAAT market

Based on technology, the isothermal nucleic acid amplification technology market is segmented into loop-mediated isothermal amplification (LAMP), transcription-mediated amplification (TMA), strand displacement amplification (SDA), nicking enzyme amplification reaction (NEAR), single-primer isothermal amplification (SPIA), and other technologies. In 2022, the loop-mediated isothermal amplification (LAMP) segment dominated the market. This is owing to high demand for LAMP kits and wide availability of these kits in developed and developing markets across the globe.

Infectious disease diagnosis segment accounted for the largest application segment of the market

Based on application, the INAAT market is segmented into infectious disease diagnosis, blood screening, and other applications. The disease diagnosis segment is expected to dominate the market in 2022. Various factors drive the growth of the segment are rising number of HIV, influenza, and hepatitis cases across the globe, focus on infectious disease control, and use of INAAT based kits for the diagnosis of these diseases.

The prominent players in isothermal nucleic acid amplification technology market are Grifols, S.A. (Spain), Hologic, Inc. (US), Abbott Laboratories (US), Becton, Dickinson and Company (US), Meridian Bioscience (US), Eiken Chemical Co., Ltd. (Japan), bioMerieux SA (France), Tecan Trading AG (Switzerland), New England Biolabs (US), QIAGEN N.V. (Germany), DiaSorin S.p.A. (Italy), General Electric (US), OptiGene Limited (UK), Quidel Corporation (US), Thermo Fisher Scientific (US), Genomtec (Poland), Mast Group Ltd. (UK), Ustar Biotechnologies (China), Jena Bioscience GmbH (Germany), Atila BioSystems (US), TwistDx Limited (UK), LGC Limited (UK), Life Sciences Advanced Technologies (US), GenoSensor Corporation (US), and PCR Biosystems (UK).

"North America: Accounted for the largest share in isothermal nucleic acid amplification technology market"

North America has the largest share of the isothermal nucleic acid amplification technology market. Factors such as availability of research funding and the development of diagnostic industry, increasing importance of early diagnosis for patient with HIV, Hepatitis and Influenza, and developed healthcare infrastructure are the major factors driving the market growth.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 80% and Demand Side - 20%
  • By Designation: Managers- 45%, CXOs and Director level - 30%, and Executives - 25%
  • By Region: North America -20%, Europe -15%, Asia-Pacific -55%, RoW -10%

List of Companies Profiled in the Report:

  • Grifols, S.A. (Spain)
  • Hologic, Inc. (US)
  • Abbott Laboratories (US)
  • Becton, Dickinson and Company (US)
  • Meridian Bioscience (US)
  • Eiken Chemical Co., Ltd. (Japan)
  • bioMerieux SA (France)
  • Tecan Trading AG (Switzerland)
  • New England Biolabs (US)
  • QIAGEN N.V. (Germany)
  • DiaSorin S.p.A. (Italy)
  • General Electric (US)
  • OptiGene Limited (UK)
  • Quidel Corporation (US)
  • Thermo Fisher Scientific (US)
  • Genomtec (Poland)
  • Mast Group Ltd. (UK)
  • Ustar Biotechnologies (China)
  • Jena Bioscience GmbH (Germany)
  • Atila BioSystems (US)
  • TwistDx Limited (UK)
  • LGC Limited (UK)
  • Life Sciences Advanced Technologies (US)
  • GenoSensor Corporation (US)
  • PCR Biosystems (UK)

Research Coverage:

This report provides a detailed picture of the isothermal nucleic acid amplification technology market. It aims at estimating the size and future growth potential of the market across different segments such as the product, application, end users and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall isothermal nucleic acid amplification technology market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • FIGURE 1 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SEGMENTATION
    • 1.3.1 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 PRIMARY RESEARCH
    • FIGURE 3 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: PRIMARY RESPONDENTS
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 4 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2022
    • FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022
    • 2.2.1 INSIGHTS FROM PRIMARY EXPERTS
    • FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY RESOURCES
  • 2.3 MARKET GROWTH RATE PROJECTIONS
    • FIGURE 7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: CAGR PROJECTIONS, 2023-2028
    • FIGURE 8 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
  • 2.4 DATA TRIANGULATION
    • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RISK ANALYSIS
  • 2.7 RECESSION IMPACT

3 EXECUTIVE SUMMARY

    • FIGURE 10 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    • FIGURE 11 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 14 GEOGRAPHICAL SNAPSHOT OF ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET

4 PREMIUM INSIGHTS

  • 4.1 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET OVERVIEW
    • FIGURE 15 INCREASING PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET GROWTH
  • 4.2 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT AND COUNTRY (2022)
    • FIGURE 16 ASSAYS, KITS, AND REAGENTS ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
  • 4.3 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SHARE, BY APPLICATION, 2023 VS. 2028
    • FIGURE 17 DISEASE DIAGNOSIS APPLICATION SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2028
  • 4.4 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 19 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • TABLE 1 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Recent launches of INAAT consumables by prominent market players
      • 5.2.1.2 Growing funding initiatives for molecular diagnostics & infectious disease diagnostics
      • 5.2.1.3 High prevalence of infectious diseases
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Unfavorable reimbursement scenario for in vitro diagnostic tests
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 INAAT tests as point-of-care tools
      • 5.2.3.2 Start-ups focusing on INAAT
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Dominance of PCR
  • 5.3 PRICING ANALYSIS
    • TABLE 2 AVERAGE SELLING PRICE OF INAAT PRODUCTS, 2022
  • 5.4 VALUE CHAIN ANALYSIS
    • FIGURE 20 VALUE CHAIN OF INAAT MARKET: MAXIMUM VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
  • 5.5 ECOSYSTEM ANALYSIS
    • FIGURE 21 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: ECOSYSTEM ANALYSIS
    • TABLE 3 SUPPLY CHAIN ECOSYSTEM
  • 5.6 KEY CONFERENCES & EVENTS IN 2023-2024
    • TABLE 4 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • 5.7 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 5 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.7.1 THREAT FROM NEW ENTRANTS
    • 5.7.2 THREAT FROM SUBSTITUTES
    • 5.7.3 BARGAINING POWER OF BUYERS
    • 5.7.4 BARGAINING POWER OF SUPPLIERS
    • 5.7.5 DEGREE OF COMPETITION
  • 5.8 KEY STAKEHOLDERS & BUYING CRITERIA
    • FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF INAAT PRODUCTS
    • FIGURE 23 BUYING CRITERIA FOR INAAT PRODUCTS
  • 5.9 PATENT ANALYSIS
    • FIGURE 24 PATENT APPLICATIONS RELATED TO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, JANUARY 2012-DECEMBER 2022
  • 5.10 REGULATORY ANALYSIS
    • TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 9 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.10.1 NORTH AMERICA
      • 5.10.1.1 US
      • 5.10.1.2 Canada
    • 5.10.2 EUROPE
    • TABLE 10 EUROPE: CLASSIFICATION OF DEVICES
    • 5.10.3 ASIA PACIFIC
      • 5.10.3.1 China
      • 5.10.3.2 Japan
      • 5.10.3.3 India
    • 5.10.4 LATIN AMERICA
      • 5.10.4.1 Brazil
      • 5.10.4.2 Mexico
    • 5.10.5 MIDDLE EAST
  • 5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 25 REVENUE SHIFT AND NEW REVENUE POCKETS

6 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 11 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • 6.2 ASSAYS, KITS, AND REAGENTS
    • 6.2.1 GROWING AWARENESS OF INAAT TO DRIVE DEMAND FOR ASSAYS, KITS, AND REAGENTS
    • TABLE 12 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY ASSAYS, KITS, AND REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 13 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 14 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 15 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3 SYSTEMS
    • 6.3.1 GROWING POPULARITY OF INAAT SYSTEMS TO SUPPORT MARKET GROWTH
    • TABLE 16 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 17 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 18 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 19 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY

  • 7.1 INTRODUCTION
    • TABLE 20 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGIES
    • TABLE 21 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • 7.2 LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP)
    • 7.2.1 LAUNCH OF NEW LAMP DIAGNOSTIC KITS TO SUPPORT MARKET GROWTH
    • TABLE 22 LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 23 NORTH AMERICA: LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 24 EUROPE: LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 25 ASIA PACIFIC: LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.3 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA)
    • 7.3.1 GROWING EFFORTS TO DEVELOP TMA KITS TO BOOST GROWTH
    • TABLE 26 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 27 NORTH AMERICA: TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 28 EUROPE: TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 29 ASIA PACIFIC: TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.4 NICKING ENZYME AMPLIFICATION REACTION (NEAR)
    • 7.4.1 RAPID IDENTIFICATION OF SMALL DNA OR RNA FRAGMENTS TO BOOST ADOPTION OF NEAR
    • TABLE 30 NICKING ENZYME AMPLIFICATION REACTION (NEAR) MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 31 NORTH AMERICA: NICKING ENZYME AMPLIFICATION REACTION (NEAR) MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 32 EUROPE: NICKING ENZYME AMPLIFICATION REACTION (NEAR) MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 33 ASIA PACIFIC: NICKING ENZYME AMPLIFICATION REACTION (NEAR) MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.5 STRAND DISPLACEMENT AMPLIFICATION (SDA)
    • 7.5.1 GROWING USE OF SDA IN RNA AMPLIFICATION TO PROPEL MARKET GROWTH
    • TABLE 34 STRAND DISPLACEMENT AMPLIFICATION (SDA) MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 35 NORTH AMERICA: STRAND DISPLACEMENT AMPLIFICATION (SDA) MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 36 EUROPE: STRAND DISPLACEMENT AMPLIFICATION (SDA) MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 37 ASIA PACIFIC: STRAND DISPLACEMENT AMPLIFICATION (SDA) MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.6 HELICASE-DEPENDENT AMPLIFICATION (HDA)
    • 7.6.1 USE OF THERMOSTABLE HELICASE ENZYMES INSTEAD OF HEAT TO BOOST DEMAND FOR HDA
    • TABLE 38 HELICASE-DEPENDENT AMPLIFICATION (HDA) MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 39 NORTH AMERICA: HELICASE-DEPENDENT AMPLIFICATION (HDA) MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 40 EUROPE: HELICASE-DEPENDENT AMPLIFICATION (HDA) MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 41 ASIA PACIFIC: HELICASE-DEPENDENT AMPLIFICATION (HDA) MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.7 NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA)
    • 7.7.1 ADVANTAGES OF NASBA OVER PCR TO BOOST ADOPTION IN CLINICAL SETTINGS
    • TABLE 42 NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 43 NORTH AMERICA: NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 44 EUROPE: NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 45 ASIA PACIFIC: NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.8 SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA)
    • 7.8.1 USE OF RNA/DNA-3' PRIMER FOR FIRST-STRAND CDNA SYNTHESIS TO DRIVE MARKET
    • TABLE 46 SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 47 NORTH AMERICA: SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 48 EUROPE: SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 49 ASIA PACIFIC: SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.9 OTHER TECHNOLOGIES
    • TABLE 50 OTHER INAAT TECHNOLOGIES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 51 NORTH AMERICA: OTHER INAAT TECHNOLOGIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 52 EUROPE: OTHER INAAT TECHNOLOGIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 53 ASIA PACIFIC: OTHER INAAT TECHNOLOGIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

8 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 54 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 8.2 DISEASE DIAGNOSIS
    • TABLE 55 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 56 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 57 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 58 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 59 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 8.2.1 COVID-19
      • 8.2.1.1 Extensive use of INAAT kits for COVID-19 diagnosis to support market growth
    • TABLE 60 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR COVID-19 TESTING, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 61 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR COVID-19 TESTING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 62 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR COVID-19 TESTING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 63 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR COVID-19 TESTING, BY COUNTRY, 2021-2028 (USD MILLION)
    • 8.2.2 HEPATITIS
      • 8.2.2.1 Growing adoption of advanced technologies for diagnosis of hepatitis B to drive growth
    • FIGURE 26 NEW CASES OF HEPATITIS B AND HEPATITIS C WORLDWIDE, BY GENDER, 2020
    • TABLE 64 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HEPATITIS TESTING, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 65 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HEPATITIS TESTING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 66 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HEPATITIS TESTING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 67 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HEPATITIS TESTING, BY COUNTRY, 2021-2028 (USD MILLION)
    • 8.2.3 CT/NG
      • 8.2.3.1 Growing prevalence of CT/NG infections worldwide to boost market
    • TABLE 68 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR CT/NG TESTING, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 69 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR CT/NG TESTING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 70 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR CT/NG TESTING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 71 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR CT/NG TESTING, BY COUNTRY, 2021-2028 (USD MILLION)
    • 8.2.4 INFLUENZA
      • 8.2.4.1 Growing focus on containing spread of influenza to propel growth
    • TABLE 72 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR INFLUENZA TESTING, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 73 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR INFLUENZA TESTING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 74 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR INFLUENZA TESTING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 75 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR INFLUENZA TESTING, BY COUNTRY, 2021-2028 (USD MILLION)
    • 8.2.5 HIV
      • 8.2.5.1 High global incidence of HIV to support market growth
    • TABLE 76 GLOBAL HIV CASES, 2021
    • TABLE 77 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HIV TESTING, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 78 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HIV TESTING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 79 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HIV TESTING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 80 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HIV TESTING, BY COUNTRY, 2021-2028 (USD MILLION)
    • 8.2.6 OTHER DISEASES
    • TABLE 81 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER DISEASES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 82 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 83 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 84 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.3 BLOOD SCREENING
    • 8.3.1 INCREASING NUMBER OF BLOOD DONATIONS AND TRANSFUSIONS TO INCREASE USE OF INAAT IN BLOOD SCREENING APPLICATIONS
    • TABLE 85 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR BLOOD SCREENING APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 86 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR BLOOD SCREENING APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 87 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR BLOOD SCREENING APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 88 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR BLOOD SCREENING APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.4 OTHER APPLICATIONS
    • TABLE 89 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 90 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 91 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 92 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)

9 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 93 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.2 HOSPITALS
    • 9.2.1 HOSPITALS TO DOMINATE INAAT MARKET DURING FORECAST PERIOD
    • TABLE 94 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HOSPITALS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 95 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HOSPITALS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 96 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HOSPITALS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 97 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HOSPITALS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.3 REFERENCE LABORATORIES
    • 9.3.1 AVAILABILITY OF WIDE RANGE OF TEST PANELS FOR INFECTIOUS DISEASE TESTING TO SUPPORT MARKET
    • TABLE 98 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR REFERENCE LABORATORIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 99 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 100 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 101 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.4 ACADEMIC & RESEARCH INSTITUTES
    • 9.4.1 GROWING USE OF INAAT ASSAYS BY ACADEMIC & RESEARCH INSTITUTES TO BOOST MARKET
    • TABLE 102 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 103 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 104 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 105 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.5 OTHER END USERS
    • TABLE 106 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 107 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 108 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 109 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)

10 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 110 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 27 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SNAPSHOT
    • TABLE 111 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 112 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 113 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 114 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 115 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 116 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 Increasing approvals of INAAT products to drive market growth
    • TABLE 117 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 118 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 119 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 120 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 121 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Growing demand for molecular diagnostic kits to boost adoption of INAAT
    • TABLE 122 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 123 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 124 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 125 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 126 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.3 NORTH AMERICA: RECESSION IMPACT
  • 10.3 EUROPE
    • TABLE 127 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 128 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 129 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 130 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 131 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 132 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Germany to dominate European isothermal nucleic acid amplification technology market during forecast period
    • TABLE 133 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 134 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 135 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 136 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 137 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 Growing adoption of INAAT products to support market growth in UK
    • TABLE 138 NUMBER OF BLOOD DONATIONS IN UK, 2016-2020
    • TABLE 139 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 140 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 141 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 142 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 143 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Established blood screening regulations to boost growth
    • TABLE 144 HIV DATA FOR FRANCE, 2021
    • TABLE 145 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 146 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 147 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 148 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 149 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Favorable government initiatives for blood transfusion to support growth
    • TABLE 150 HIV DATA FOR ITALY, 2021
    • TABLE 151 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 152 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 153 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 154 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 155 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Growing demand for diagnostic testing in Spain to favor market growth
    • TABLE 156 HIV DATA FOR SPAIN, 2021
    • TABLE 157 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 158 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 159 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 160 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 161 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 162 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 163 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 164 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 165 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 166 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.7 EUROPE: RECESSION IMPACT
  • 10.4 ASIA PACIFIC
    • FIGURE 28 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SNAPSHOT
    • TABLE 167 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 168 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 169 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 170 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 171 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 172 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.1 CHINA
      • 10.4.1.1 China to dominate APAC INAAT market during forecast period
    • TABLE 173 CHINA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 174 CHINA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 175 CHINA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 176 CHINA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 177 CHINA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.2 JAPAN
      • 10.4.2.1 Universal healthcare reimbursement policy to drive market growth in Japan
    • TABLE 178 JAPAN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 179 JAPAN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 180 JAPAN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 181 JAPAN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 182 JAPAN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Government initiatives for blood donation to contribute to growth
    • TABLE 183 INDIA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 184 INDIA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 185 INDIA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 186 INDIA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 187 INDIA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.4 REST OF ASIA PACIFIC
    • TABLE 188 REST OF ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 189 REST OF ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 190 REST OF ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 191 REST OF ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 192 REST OF ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.5 ASIA PACIFIC: RECESSION IMPACT
  • 10.5 LATIN AMERICA
    • 10.5.1 GROWING AWARENESS ABOUT INAAT TO PROPEL GROWTH
    • TABLE 193 LATIN AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 194 LATIN AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 195 LATIN AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 196 LATIN AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 197 LATIN AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.2 LATIN AMERICA: RECESSION IMPACT
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
    • TABLE 198 MIDDLE EAST & AFRICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 199 MIDDLE EAST & AFRICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 200 MIDDLE EAST & AFRICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 201 MIDDLE EAST & AFRICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 202 MIDDLE EAST & AFRICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
    • FIGURE 29 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: STRATEGIES ADOPTED
  • 11.3 REVENUE SHARE ANALYSIS
    • FIGURE 30 REVENUE ANALYSIS OF KEY COMPANIES (2020-2022)
  • 11.4 MARKET SHARE ANALYSIS
    • FIGURE 31 MARKET SHARE ANALYSIS OF KEY COMPANIES (2022)
    • TABLE 203 INAAT MARKET: DEGREE OF COMPETITION
  • 11.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 32 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: COMPANY EVALUATION MATRIX, 2022
  • 11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
    • 11.6.1 OVERALL COMPANY FOOTPRINT (25 COMPANIES)
    • TABLE 204 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
    • 11.6.2 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES)
    • TABLE 205 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS
    • 11.6.3 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
    • TABLE 206 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
  • 11.7 COMPANY EVALUATION MATRIX FOR START-UPS/SMES
    • 11.7.1 PROGRESSIVE COMPANIES
    • 11.7.2 STARTING BLOCKS
    • 11.7.3 RESPONSIVE COMPANIES
    • 11.7.4 DYNAMIC COMPANIES
    • FIGURE 33 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
  • 11.8 COMPETITIVE BENCHMARKING OF START-UPS/SMES
    • TABLE 207 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: DETAILED LIST OF KEY START-UPS/SMES
    • TABLE 208 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
  • 11.9 COMPETITIVE SCENARIO AND TRENDS
    • 11.9.1 PRODUCT LAUNCHES
    • TABLE 209 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: KEY PRODUCT LAUNCHES, JANUARY 2020- JANUARY 2023
    • 11.9.2 DEALS
    • TABLE 210 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: KEY DEALS, JANUARY 2020-JANUARY 2023
    • 11.9.3 OTHER DEVELOPMENTS
    • TABLE 211 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: OTHER KEY DEVELOPMENTS, JANUARY 2020-JANUARY 2023

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS

(Business overview, Products offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses & competitive threats)*

    • 12.1.1 HOLOGIC, INC.
    • TABLE 212 HOLOGIC, INC.: BUSINESS OVERVIEW
    • FIGURE 34 HOLOGIC, INC.: COMPANY SNAPSHOT (2022)
    • 12.1.2 ABBOTT LABORATORIES
    • TABLE 213 ABBOTT LABORATORIES: BUSINESS OVERVIEW
    • FIGURE 35 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
    • 12.1.3 GRIFOLS, S.A.
    • TABLE 214 GRIFOLS, S.A.: BUSINESS OVERVIEW
    • FIGURE 36 GRIFOLS, S.A.: COMPANY SNAPSHOT (2021)
    • 12.1.4 BECTON, DICKINSON AND COMPANY
    • TABLE 215 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
    • FIGURE 37 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
    • 12.1.5 MERIDIAN BIOSCIENCE
    • TABLE 216 MERIDIAN BIOSCIENCE: BUSINESS OVERVIEW
    • FIGURE 38 MERIDIAN BIOSCIENCE: COMPANY SNAPSHOT (2022)
    • 12.1.6 EIKEN CHEMICAL CO., LTD.
    • TABLE 217 EIKEN CHEMICAL CO., LTD.: BUSINESS OVERVIEW
    • FIGURE 39 EIKEN CHEMICAL CO., LTD.: COMPANY SNAPSHOT (2021)
    • 12.1.7 QUIDEL CORPORATION
    • TABLE 218 QUIDEL CORPORATION: BUSINESS OVERVIEW
    • FIGURE 40 QUIDEL CORPORATION: COMPANY SNAPSHOT (2021)
    • 12.1.8 QIAGEN N.V.
    • TABLE 219 QIAGEN N.V.: BUSINESS OVERVIEW
    • FIGURE 41 QIAGEN N.V.: COMPANY SNAPSHOT (2021)
    • 12.1.9 NEW ENGLAND BIOLABS
    • TABLE 220 NEW ENGLAND BIOLABS: BUSINESS OVERVIEW
    • 12.1.10 DIASORIN S.P.A.
    • TABLE 221 DIASORIN S.P.A.: BUSINESS OVERVIEW
    • FIGURE 42 DIASORIN S.P.A.: COMPANY SNAPSHOT (2021)
    • 12.1.11 BIOMERIEUX SA
    • TABLE 222 BIOMERIEUX SA: BUSINESS OVERVIEW
    • FIGURE 43 BIOMERIEUX SA: COMPANY SNAPSHOT (2021)
    • 12.1.12 TECAN TRADING GROUP
    • TABLE 223 TECAN TRADING GROUP: BUSINESS OVERVIEW
    • FIGURE 44 TECAN TRADING GROUP: COMPANY SNAPSHOT (2021)
    • 12.1.13 GENERAL ELECTRIC COMPANY
    • TABLE 224 GENERAL ELECTRIC COMPANY: BUSINESS OVERVIEW
    • FIGURE 45 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT (2021)
    • 12.1.14 THERMO FISHER SCIENTIFIC
    • TABLE 225 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
    • FIGURE 46 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2021)
    • 12.1.15 OPTIGENE LIMITED
    • TABLE 226 OPTIGENE LIMITED: BUSINESS OVERVIEW
  • 12.2 OTHER COMPANIES
    • 12.2.1 LGC LIMITED
    • 12.2.2 USTAR BIOTECHNOLOGIES
    • 12.2.3 TWISTDX LIMITED
    • 12.2.4 MAST GROUP LTD.
    • 12.2.5 GENOMTEC
    • 12.2.6 GENOSENSOR CORPORATION
    • 12.2.7 JENA BIOSCIENCE GMBH
    • 12.2.8 LIFE SCIENCES ADVANCED TECHNOLOGIES
    • 12.2.9 PCR BIOSYSTEMS
    • 12.2.10 ATILA BIOSYSTEMS

Details on Business overview, Products offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses & competitive threats might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS